Online citations, reference lists, and bibliographies.
← Back to Search

The Effect Of Different Oils On The Absorption Of Probucol In The Rat

K. Palin, C. Wilson
Published 1984 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The effect of oily vehicles on the gastrointestinal absorption of the hypocholesterolaemic agent probucol has been investigated in the rat. The plasma concentration was determined following its administration in arachis oil (peanut oil), Miglyol 812 (fractionated coconut oil) and liquid paraffin. The total absorption of the drug, calculated as the area under the plasma concentration time curve, was significantly greater for the arachis oil formulation than with the other vehicles. The drug was selectively absorbed via the lymphatic system, lymph drug concentrations being highest following co‐administration of arachis oil.
This paper references



This paper is referenced by
10.1002/JPS.20403
Bioavailability of seocalcitol I: Relating solubility in biorelevant media with oral bioavailability in rats--effect of medium and long chain triglycerides.
M. Grove (2005)
10.1111/j.2042-7158.1987.tb07164.x
Lipid vehicles for intestinal lymphatic drug absorption
M. Cheema (1987)
10.1016/0378-5173(94)00336-4
Mechanism of promotion of lymphatic drug absorption by milk fat globule membrane
H. Liu (1995)
10.1016/b978-0-444-81871-3.50011-4
[Oral drug administration].
O. Delgado (1997)
10.1002/JPS.2600840202
Pharmacokinetics of the acyl coenzyme A:cholesterol acyl transferase inhibitor CP-105,191 in dogs--the effect of food and sesame oil on systemic exposure following oral dosing.
P. Inskeep (1995)
10.1016/S0378-5173(98)00054-4
Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine
Shui-Mei Khoo (1998)
10.1016/0378-5173(92)90261-Y
Factors affecting the lymphatic transport of penclomedine (NSC-338720), a lipophilic cytotoxic drug: Comparison to DDT and hexachlorobenzene
R. A. Myers (1992)
10.1016/J.VASCN.2003.11.004
A stepwise surgical procedure to investigate the lymphatic transport of lipid-based oral drug formulations: Cannulation of the mesenteric and thoracic lymph ducts within the rat.
M. Boyd (2004)
10.1016/S0169-409X(96)00492-9
Uptake of drugs into the intestinal lymphatics after oral administration
C. H. Porter (1997)
10.1080/10915810160233776
Final Report on the Safety Assessment of Peanut (Arachis Hypogaea) Oil, Hydrogenated Peanut Oil, Peanut Acid, Peanut Glycerides, and Peanut (Arachis Hypogaea) Flour
F. Andersen (2001)
10.1007/978-0-387-49785-3_18
Lymphatic Absorption of Orally Administered Prodrugs
David M. Shackleford (2007)
10.1016/0378-5173(94)00390-Q
Effect of lipid vehicle on the intestinal lymphatic transport of isotretinoin in the rat
R. Nankervis (1995)
10.1016/0378-5173(96)04585-1
In vitro study of cyclosporin absorption: Vehicles and intestinal immaturity
J. Penaud (1996)
10.1081/RRS-100107429
LIPID-BASED FORMULATIONS FOR ORAL ADMINISTRATION: OPPORTUNITIES FOR BIOAVAILABILITY ENHANCEMENT AND LIPOPROTEIN TARGETING OF LIPOPHILIC DRUGS
C. J. Porter (2001)
10.1016/S0378-5173(97)00392-X
Lymphatic uptake of MK-386, a sterol 5α-reductase inhibitor, from aqueous and lipid formulations
G. Kwei (1998)
10.1016/j.ijpharm.2014.02.013
A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
Congcong Lin (2014)
Drug dissolution under physiologically relevant conditions in vitro and in vivo.
E. Persson (2006)
10.1016/B978-0-12-013321-5.50006-0
Drug Targeting Towards the Lymphatics
S. Muranishi (1991)
10.1016/j.jconrel.2008.03.021
Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
A. Dahan (2008)
10.1016/0045-6535(87)90056-7
Vehicle dependent bioavailability of polychlorinated dibenzo-p-dioxins (PCDDs) and -dibenzofurans (PCDFs) in the rat
M. Berg (1987)
Development of potential Self-microemulsifying lipid formulation for the oral administration of Curcumin
Naser M. Y. Hasan (2015)
10.1016/S0169-409X(01)00151-X
Intestinal lymphatic drug transport: an update.
C. J. Porter (2001)
10.1007/978-0-387-44961-6_6
Lipid-based Systems, Drug Exposure and Lead Optimization
W. Charman (2006)
10.4155/tde-2018-0036
Eudragit®-based microcapsules of probucol with a gut-bacterial processed secondary bile acid.
A. Mooranian (2018)
10.1016/S0169-409X(96)00494-2
Lipid-based vehicles for the oral delivery of poorly water soluble drugs
A. Humberstone (1997)
10.2174/1567201816666181227111912
Probucol Self-Emulsified Drug Delivery System: Stability Testing and Bioavailability Assessment in Human Volunteers.
A. Zaghloul (2019)
10.1016/S0378-5173(99)00166-0
Synthesis and characterisation of palymitoyl propanolol hydrochloride auto-lymphotrophs for oral administration.
S. Vyas (1999)
10.1201/B14005-11
Administration of Emulsions to the Gastrointestinal Tract
D. Craig (2000)
10.1016/0169-409X(95)00105-G
Lipophilic prodrugs designed for intestinal lymphatic transport
W. Charman (1996)
10.3390/ijms21093248
Lipids and Lipid-Processing Pathways in Drug Delivery and Therapeutics
Milica Markovic (2020)
10.1007/978-1-4899-1863-5_6
Model systems for intestinal lymphatic transport studies.
C. J. Porter (1996)
10.1248/BPB.31.321
In vivo assessment of oral administration of probucol nanoparticles in rats.
Jyutaro Shudo (2008)
See more
Semantic Scholar Logo Some data provided by SemanticScholar